37 states and 5 U.S. dependent areas with confidential name-based HIV infection reporting
Heterosexual contact with a person known to have, or be at high risk for, HIV infection.
Other includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
Male-to-male sexual contact: United States 77.1%; Central America 67.1%; South America 79.7%; Cuba 75.6%; Mexico 73.3%; Puerto Rico 43.4%; Total 69.1%. Injection drug use: United States 10.5%; Central America 6.2%; South America 4.3%; Cuba 4.0%; Mexico 7.2%; Puerto Rico 32.5%; Total 13.5%. Male-to-male sexual contact and injection drug use: United States 4.1%; Central America 2.1%; South America 2.3%; Cuba 2.5%; Mexico 3.9%; Puerto Rico 4.1%; Total 3.7%. Other: United States 0.2%; Central America 0.8%; South America 0.1%; Cuba 1.0%; Mexico 0.3%; Puerto Rico 0.0%; Total 0.3%.
Injection drug use: United States 20.3%; Central America 5.9%; South America 11.3%; Cuba 12.6%; Mexico 5.1%; Puerto Rico 15.1%; Total 15.5%. Heterosexual contact: United States 79.1%; Central America 92.7%; South America 87.6%; Cuba 87.4%; Mexico 94.3%; Puerto Rico 84.2%; Total 83.7%. Other: United States 0.6%; Central America 1.4%; South America 1.1%; Cuba 0.0%; Mexico 0.6%; Puerto Rico 0.7%; Total 0.8%.